Log in to save to my catalogue

Central nervous system uptake of intranasal glutathione in Parkinson’s disease

Central nervous system uptake of intranasal glutathione in Parkinson’s disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5516583

Central nervous system uptake of intranasal glutathione in Parkinson’s disease

About this item

Full title

Central nervous system uptake of intranasal glutathione in Parkinson’s disease

Publisher

London: Nature Publishing Group UK

Journal title

NPJ Parkinson's Disease, 2016-02, Vol.2 (1), p.16002-16002, Article 16002

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Glutathione (GSH) is depleted early in the course of Parkinson’s disease (PD), and deficiency has been shown to perpetuate oxidative stress, mitochondrial dysfunction, impaired autophagy, and cell death. GSH repletion has been proposed as a therapeutic intervention. The objective of this study was to evaluate whether intranasally administered reduc...

Alternative Titles

Full title

Central nervous system uptake of intranasal glutathione in Parkinson’s disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5516583

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5516583

Other Identifiers

ISSN

2373-8057

E-ISSN

2373-8057

DOI

10.1038/npjparkd.2016.2

How to access this item